AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in Epigenetic Reprogramming
This chapter highlights the recent breakthroughs at Life Biosciences, particularly focusing on their clinical trials in partial epigenetic reprogramming for optic neuropathies. It also discusses their accolades, including recognition as a top biotech in Boston and participation in significant medical conferences, showcasing their innovative contributions to the field.